Cathie Wood’s Latest Thoughts on Inflation and Her 5 Worst-Performing Stock Picks

3. Berkeley Lights, Inc. (NASDAQ:BLI)

Number of Hedge Fund Holders: 16

Loss in Share Price Year-to-Date as of June 30: 74.92%

Berkeley Lights, Inc. (NASDAQ:BLI) is a digital cell biology company. Regulatory filings reveal that ARK owned over 8.3 million shares of Berkeley Lights, Inc. (NASDAQ:BLI) at the end of March 2022 worth $59 million, representing 0.24% of the total portfolio. On June 6, contract development firm Curia announced that it would adopt the Beacon Optofluidic system offered by Berkeley to “accelerate antibody-based drug discovery capabilities”. Curia will be able to deliver antibody sequences with data analysis within weeks through the adoption. 

On May 9, Berkeley Lights, Inc. (NASDAQ:BLI) posted earnings for the first quarter of 2022, missing market estimates on earnings per share by $0.01. The revenue over the period was $20 million, roughly in line with market expectations. 

Among the hedge funds being tracked by Insider Monkey, New York-based investment firm Two Sigma Advisors is a leading shareholder in Berkeley Lights, Inc. (NASDAQ:BLI), with 1 million shares worth more than $7.8 million.